These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 241604)

  • 1. Treatment of 'brain fag' syndrome.
    Anumonye A
    Curr Med Res Opin; 1975; 3(6):367-70. PubMed ID: 241604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Mercier P; Beaudry P; Annable L; Chouinard G
    Acta Psychiatr Scand; 1986 Nov; 74(5):451-8. PubMed ID: 2880459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam in the treatment of neurosis.
    Lameiras JC
    Curr Med Res Opin; 1976; 4(6):441-5. PubMed ID: 11961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K; Fox IL; Greenblatt DJ; Sandler KR; Schless A
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report].
    Schylla A; Scisło P; Badura-Brzoza K; Pasierb N
    Wiad Lek; 2012; 65(4):243-6. PubMed ID: 23654146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous lorazepam in the acute anxiety crisis: a preliminary report on 60 cases.
    Gomez-Lozano P
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):469-74. PubMed ID: 4285
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L; Schatzberg AF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 17. Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
    Mandos LA; Rickels K; Cutler N; Roeschen J; Keppel Hesselink JM; Schweizer E
    Int Clin Psychopharmacol; 1995 Nov; 10(4):251-6. PubMed ID: 8748047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 19. A test of the concept of "underlying depressive illness" in the treatment of anxiety states.
    Walsh MR; Dunckley HG; Sinclair JM; Schiff AA
    Curr Med Res Opin; 1976; 4(5):340-5. PubMed ID: 12915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.